Efficacy and Safety of Crisugabalin (HSK16149) in Adults with Postherpetic Neuralgia: A Phase 3 Randomized Clinical Trial.
Xiangkui Li, Zhigang Cheng, Tingting Wu, Wenzhong Wu, Rixin Chen, Liming Wu, Zhuobo Zhang, Guoqiang Zhang, Huiping Wang, Xiuping Han, Qianjin Lu, Linfeng Li, Changyi Liu, Xiaoyan Chen, Nan Yu, Jianyun Lu, Tong Zhang, Chenyu Li, Yaping Wang, Jianglin Zhang, Dongmei Wang, Ying Gao, Dong Yang, Li Wan, Hui Sun, Xin Li, Weiyi Zhang, Yu Wang, Wenhao Yin, Chunshui Yu, Zhehu Jin, Zhiying Feng, Daying Zhang, Tiechi Lei, Lanying Qin, Xuewu Lin, Shoumin Zhang, Kemei Shi, Zhenling Yang, Xiumin Yang, Xiaohong Ba, Guonian Wang, Shoumin Zhu, Jihai Shi, Zhijian Ye, Chunjun Yang, Shousi Lu, Nianyue Bai, Pingping Qin, Tangde Zhang, Fangqiong Li
JAMA dermatology 2024;160(11):1182-1191